Axonal-Biostatem becomes Heva

Axonal-Biostatem becomes Heva, Docaposte subsidiary, and La Poste Sante & Autonomie brand, as a key player in the processing of health data for research purposes in an ethical, secure and sovereign framework. For more than 30 years, we have specialized in supporting our clients in the design, implementation and analysis of clinical research projects and non-interventional studies. Drawing on our medical and scientific expertise, we adapt to each project in an agile manner. Our offering includes all internal services and supports pharmaceutical industries, medical device industries, biotechnology companies and academic sponsors in the management: - clinical trials - Phase I...

Clinical trials,real world evidence,regulatory submissions,medical writing services,drugs,medical device,nutrition,and full service cro

Axonal-biostatem becomes heva operates in the Pharmaceutical manufacturing industry.

Axonal-biostatem becomes heva's revenue is 11m - 100m

Axonal-biostatem becomes heva has 51 - 200 employees.